UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Lymphoma Studies

For patients infected with HIV and lymphoma, the UCLA CARE Center has studies available.

For an overview of all the UCLA CARE Center's lymphoma and HIV studies, Click Here »

AMC 053
Study examining bortezomib given together with dexamethasone, ifosfamide, carboplatin, and etoposide to see how well it works with or without rituximab in treating patients with relapsed or refractory AIDS-related non-Hodgkin lymphoma.

AMC 075
Study examining if vorinostat may improve the effectiveness of chemotherapy in patients with HIV and non-Hodgkin lymphoma.

AMC 080
Study examining the risks and benefits of allogeneic stem cell transplant for men and women with acute myeloid leukemia (AML) or acute lymphocytic leukemia (ALL) in first or second remission (CR) and HIV infection.

AMC 083
Tissue collection study to examine outcomes, immune response and progression of various malignancies in association with HIV.  Individuals with diffuse large B-cell lymphoma, non small-cell lung malignancy, anal or cervical cancer may be eligible to participate.

For more information about the UCLA CARE Center's clinical trials and research studies, please contact:
Phone:  (310) 557-9062
Email:  CAREOutreach@mednet.ucla.edu